Jun 16, 2025, 09:37
Methamphetamine Abuse Triggers Severe Thrombotic Microangiopathy
Sanjeev Sethi, Professor of Pathology and Renal Pathologist at Mayo Clinic, shared a clinical case on X.
“Methamphetamine abuse=severe thrombotic microangiopathy
Unfortunate weekend case. Glomeruli: mesangiolysis and ischemic changes
Interstitium: Hemorrhage, inflammation & scarring
Vessels: Severe sclerosis, thrombosis, schistocytes40-yr woman, hypertension, AKI, meth abuse”

In this biopsy from a 40-year-old hypertensive patient with acute kidney injury and chronic methamphetamine use, histology revealed:
- Glomeruli: marked mesangiolysis and ischemic collapse
- Interstitium: extensive hemorrhage, inflammatory infiltrates, and fibrosis
- Vessels: complete arterial occlusion, widespread thrombosis, and vascular sclerosis, with schistocyte formation
This case underscores the devastating microvascular injury drugs like methamphetamine can inflict, mimicking classic thrombotic microangiopathy. Early recognition of drug-induced TMA is critical—prompt discontinuation of the offending agent and supportive care may improve renal outcomes.
Stay up to date with Hemostasis Today for more case reviews.
-
Jun 2, 2026, 15:28Kabilan K. L.: Management and Diagnosis of Acute Coronary Syndrome Types
-
Jun 2, 2026, 15:26Mital Jhaveri: What New Data Reveal About DOACs and Androgen Receptor Inhibitors?
-
Jun 2, 2026, 15:22Dhananjaya Kotebagilu Narayana Vamyanmane: High-Resolution Ultrasound Evaluation of Bowel Wall Ischemia
-
Jun 2, 2026, 15:20Joep Schellens: Influence of Dexamethasone and Tocilizumab on Fibrinolysis in COVID-19
-
Jun 2, 2026, 15:12Ebrahim Umer: The Sickest Liver Patients Deserve One Language – Lessons from the Kyoto Consensus
-
Jun 2, 2026, 15:10Ney Carter Borges: Bempedoic Acid and Venous Thromboembolism Risk in Statin-Intolerant Patients
-
Jun 2, 2026, 15:07Sayan Koley: Coagulation Science – Where Precision Saves Lives
-
Jun 2, 2026, 15:04Ahmed Mohsen: Low CHA₂DS₂-VA Score Does Not Always Mean No Anticoagulation
-
Jun 2, 2026, 15:04The Risk Factors and Optimal Prevention Strategies of VTE in Sickle Cell Disease – RPTH Journal